UNSPSC 51473305: Bismuth tribromophenate

This classification denotes a topical anti-infective agent with the molecular formula 3C6H2Br3O.Bi, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5K96Y7WG8T, chemically known as phenol, 2,4,6-tribromo-, bismuth(3+) salt but generally known as bismuth tribromophenate, which bears US NIH Compound Identifier 78852. European Medicines Agency schedules Bismuth tribromophenate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13095MIG.

As of Q4 2014, BISMUTH TRIBROMOPHENATE remains the US FDA Preferred Term for this commodity. Bismuth tribromophenate bears US NLM identifiers UMLS ID C0106555 and NCI Concept Code C87256. SMILES: C1=C(C=C(C(=C1Br)[O-])Br)Br.C1=C(C=C(C(=C1Br)[O-])Br)Br.C1=C(C=C(C(=C1Br)[O-])Br)Br.[Bi+3].

UNSPSC 51473305 Bismuth tribromophenate is a Commodity code that does not align with the recent state and local opportunities posted under it. The two recent solicitations in the source—Hillsborough County's request for janitorial and operational supplies (ITB-26-00319) and Minnesota's multi-state cooperative purchasing RFP for generic pharmaceuticals and OTC products (S1070000015802)—are unrelated to bismuth tribromophenate, a specialty chemical compound. The code shows little relevant recent activity under its nominal scope.

State and local procurement activity does not appear to be buying bismuth tribromophenate as a standalone commodity at present. The opportunities posted under this code reflect mislabeling or administrative miscoding rather than market demand for this chemical. Practitioners should verify with issuing bodies directly whether future procurements targeting bismuth tribromophenate or related specialty chemical flame retardants and additives are planned, as the current opportunity set provides no actionable pipeline signal under the code's actual definition.